Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H - Wikidata - wikimedia - TriplyDB

Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H

Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H

http://www.wikidata.org/entity/Q24655418

about

Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1 Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1 The localization of APOBEC3H variants in HIV-1 virions determines their antiviral activity HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors The range of human APOBEC3H sensitivity to lentiviral Vif proteins A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review)Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all The APOBEC3 family of retroelement restriction factors Suppression of APOBEC3-mediated restriction of HIV-1 by Vif Intrinsic cellular defenses against human immunodeficiency viruses Evidence for selection at HIV host susceptibility genes in a West Central African human population The Role of the Antiviral APOBEC3 Gene Family in Protecting Chimpanzees against Lentiviruses from Monkeys Reduced APOBEC3H variant anti-viral activities are associated with altered RNA binding activities.Are viruses inhibited by APOBEC3 molecules from their host species?Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.HIV-1 competition experiments in humanized mice show that APOBEC3H imposes selective pressure and promotes virus adaptation Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.Vif of feline immunodeficiency virus from domestic cats protects against APOBEC3 restriction factors from many felids Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction Lentiviral Vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity.Remarkable lethal G-to-A mutations in vif-proficient HIV-1 provirus by individual APOBEC3 proteins in humanized mice Identification of two APOBEC3F splice variants displaying HIV-1 antiviral activity and contrasting sensitivity to Vif N-terminal hemagglutinin tag renders lysine-deficient APOBEC3G resistant to HIV-1 Vif-induced degradation by reduced polyubiquitination.Association between targeted somatic mutation (TSM) signatures and HGS-OvCa progression APOBEC3H haplotypes and HIV-1 pro-viral vif DNA sequence diversity in early untreated human immunodeficiency virus-1 infection.The resistance of human APOBEC3H to HIV-1 NL4-3 molecular clone is determined by a single amino acid in Vif.Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity.Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis.Sequence and structural determinants of human APOBEC3H deaminase and anti-HIV-1 activities.Identification and functional analysis of a second RBF-2 binding site within the HIV-1 promoter Overlapping Patterns of Rapid Evolution in the Nucleic Acid Sensors cGAS and OAS1 Suggest a Common Mechanism of Pathogen Antagonism and Escape.Structural Features of Antiviral APOBEC3 Proteins are Linked to Their Functional Activities.The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H Hepatitis B virus genotypes and genome characteristics in China.HIV-1 and HIV-2 exhibit similar mutation frequencies and spectra in the absence of G-to-A hypermutation.HIV Vpu Interferes with NF-κB Activity but Not with Interferon Regulatory Factor 3.Retroelements versus APOBEC3 family members: No great escape from the magnificent seven

P2860

Q21144862-9BCBC8AE-4361-4D38-A4A1-5838BC958CE8 Q24310242-70D84BA5-6A14-45FE-AA59-747B2EA1FAAD Q24321636-29C876CF-25CC-4FD7-A6F0-5677A11B94BC Q24596322-C0D54A73-A94A-4E5E-8245-5C81F3CDC4AF Q24619114-1965028D-88C7-4C21-BF32-3D25D16991C9 Q24653931-B47AD8C1-009A-463A-A22A-3C4C186D22AD Q24656551-74476DCD-0BED-464F-851B-DC2099A0CB52 Q26781812-CA9DF811-68EF-4CEE-8C4C-B4E634978408 Q26823568-2DF85CD3-5429-4646-90A9-FEA2EB52DC26 Q26862780-21847CB7-4262-44FC-801A-6DE6B588875B Q27025150-064F1794-C37E-4DFB-9718-9735185FF658 Q28659575-3F123906-1D50-452F-A3D7-291AFD958743 Q28710092-CFD3DDFB-16CB-49C8-ACBB-26FDC1D3177C Q30379417-CA7B85B9-CA4C-4849-B10E-9777DDED5EC1 Q31078477-65703EE7-7A9D-4F20-AAEA-F95878887908 Q33434458-59DDFB2F-A125-4E0A-965B-348EC1AD5959 Q33654949-9FBC7FDF-3BCF-40A9-BAC9-322D8D609D83 Q33699581-DD87246F-35A9-4D2F-9C45-B319E3494CBF Q33815187-9E5D181E-99A3-4B7C-98AF-57E00EBDC8A0 Q33966666-7D2D9DB9-16EE-4D6C-88B4-48CCD0C28D7A Q33982561-B833576C-0130-43A6-95F8-6D046F923A91 Q34020228-D0364F47-1662-42EC-B21B-6875550F20FA Q34045987-C5A6E6B9-7A34-470E-AD20-844E4A9D4FF2 Q34120265-8BE09BA9-843E-42CE-8269-D4C9773C4C8D Q34121572-DFD40E2A-97D6-4E32-8CA5-CC86C53B22FD Q34166447-059AC944-D7F7-40F5-9EEE-6AFF26FAEB7F Q34536160-4A89A2AF-6FA0-40DD-9814-9F2AD16B9271 Q34574355-063780BD-180C-4A20-95CF-D5EB0F33E10A Q34612416-61DBAD81-3CFD-4604-94AF-FA70DEFF422D Q34742607-A25CF188-8BB8-443E-BFD1-89728EFB51BE Q34805086-FDFB9741-61E2-4F62-92CC-B99A49A57367 Q35068754-D323A369-A282-4447-BE16-4CD528FDA357 Q35222092-DF34FC50-5402-4869-AE03-5EF5EA6F92D2 Q35622517-87D78D89-7197-43A3-AEB5-D1E8D8B1C4C4 Q35627352-CD8E11BB-F8A6-41DA-8ADD-D85755BCFEE5 Q35666084-E20E08AF-4B02-4AE8-9269-7E6E11AE0CE1 Q35692333-C4744E87-DE6C-4273-AE79-410A5559DBC1 Q35834559-38C4BED3-E3D8-4462-BC28-F08049B657FA Q36080904-A98DE032-5343-4B17-81E8-E42D9E42D1B1 Q36162443-23DEF841-9BBD-484E-8F45-98518B210727

P2860

Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H

http://www.wikidata.org/entity/Q24655418

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H

@ast

Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H

@en

Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H

@nl

type

label

Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H

@ast

Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H

@en

Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H

@nl

prefLabel

Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H

@ast

Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H

@en

Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H

@nl

P1433

Q24655418-FF11EC18-26A4-452E-9B26-2BD26095D092

P1476

Q24655418-097C733F-2CA3-4D94-AAC7-6629DEF7DEE6

P2093

Q24655418-53187C78-42CF-4818-BCF0-DD77B920CC4B

Q24655418-AAD1DBCF-668D-40EC-9247-BA78D811F1EF

P2860

Q24655418-0048DA4C-4B2D-4E84-AE4A-1DC365D2B03A

Q24655418-05138E30-7C25-452C-B304-6DD955AC05A5

Q24655418-0B0D3560-BA1D-4097-B6EC-F08A9C9CFD3E

Q24655418-0DAC6536-31F2-430F-A07F-99FCA725895F

Q24655418-152FB9BB-D337-444C-8E43-D52C5DA0E798

Q24655418-27096AF1-F43B-41E5-8BAD-99BC1E5A92FF

Q24655418-28273788-CD67-4313-9FF5-0AA4A9A4CD1C

Q24655418-2EF73F0E-BDA5-4E15-A5AC-51D42BF422E2

Q24655418-2F131E5C-05F5-430A-9BA8-2AC356A56300

Q24655418-3496C965-C116-49DA-A961-2F63695FC6C5

P304

Q24655418-F935580C-C587-4DC0-B9A7-EBFB265B53A2

P31

Q24655418-D27B5EF3-CC95-415B-AC5E-ECCEE9CFABAD

P3181

Q24655418-02ECD1FA-3271-42EA-AC95-34B3DB734F14

P356

Q24655418-A54130BA-34D3-438F-914A-0BD0B3974FF7

P407

Q24655418-5D1A3954-C128-4135-917C-B2367C48C61E

P433

Q24655418-00D8A14B-3D96-4D4B-A394-51BC640C061D

P478

Q24655418-1E0040B3-4595-4FD0-AAA0-1DA68F316B3C

P50

Q24655418-73735FA3-BF71-4460-94A2-B09A2CF16F97

Q24655418-B08B49B0-2711-4C27-BC9C-6887A6939FEA

P577

Q24655418-F0131ED3-86EC-46F2-B908-1D6D86D63076

P698

Q24655418-E00007A5-8C12-407C-B33F-60239F29407A

P921

Q24655418-CFD23556-165E-412A-B9FD-24B79DB0BCBC

P932

Q24655418-E5A1A55E-8E89-47F9-804A-302CDDF184F1

P3181

P356

P1433

Journal of Virology

P1476

Polymorphisms and splice variants influence the antiretroviral activity of human APOBEC3H

@en

P2093

Ariana Harari

http://www.w3.org/2001/XMLSchema#string

Lubbertus C F Mulder

http://www.w3.org/2001/XMLSchema#string

P2860

AceView: a comprehensive cDNA-supported gene and transcripts annotation

Antiretroelement activity of APOBEC3H was lost twice in recent human evolution

Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H.

Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

HIV-1 Vif, APOBEC, and intrinsic immunity

A second generation human haplotype map of over 3.1 million SNPs

Human cytidine deaminase APOBEC3H restricts HIV-1 replication

Cytidine deamination induced HIV-1 drug resistance

Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family

P304

295-303

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3663690

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/JVI.01665-08

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18945781

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

2612324

http://www.w3.org/2001/XMLSchema#string